Holiferm
The Manchester University spinout runs a commercial Wallasey plant at 1.65 kta, expanding to 3.5 kta and targeting 15 kta; its patented in-fermentation continuous gravity separation cuts OPEX by roughly 50%, making its biosurfactants price-competitive with petrochemical equivalents.
- Country
- United Kingdom
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsepareachnmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosurfactants | specialty-fine-chem | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.